Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

536.70
Delayed Data
As of Aug 28
 -1.30 / -0.24%
Today’s Change
320.06
Today|||52-Week Range
605.93
+30.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues725.8M802.3M869.6M998.6M
 
 
 
 
 
Cost of Goods Sold55.6M59.5M84.0M88.8M
 
 
 
 
 
Depreciation And Amortization14.0M14.1M16.0M15.3M
 
 
 
 
 
 
Operating ExpensesGross Income656.2M728.7M769.6M894.5M
 
 
 
 
 
General Expenses473.5M481.4M486.1M549.6M
 
 
 
 
 
Research And Development323.7M337.6M327.1M375.0M
 
 
 
 
 
Total Operating Expenses543.1M555.0M586.1M653.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income182.7M247.4M283.6M344.9M
 
 
 
 
 
Extraordinary Credit0.001.2M0.000.00
 
 
Extraordinary Charge0.00-22.7M-942.0K-16.0M
 
 
 
 
Interest Expense On Debt9.2M6.4M6.2M2.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income176.1M221.3M276.5M328.0M
 
 
 
 
 
Income Taxes-96.4M-111.1M-200.5M-133.4M
 
 
 
 
 
Net Income79.7M110.2M76.0M194.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS100.8M101.5M102.2M102.9M
 
 
 
 
 
Shares To Calculate EPS Diluted117.4M114.2M114.5M115.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.70$0.96$0.66$1.69
 
 
 
 
 
EPS Diluted$0.70$0.96$0.66$1.69